Anupam Rasayan India Ltd (ANURAS) — Board Meeting | 17 September 2026

17 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved security documents for Mates Visa Consultancy's INR 300 crore debenture issuance and related pledges.

🔄 What Changed

Approval of up to INR 300 crore debenture issuance by Mates Visa Consultancy and associated security instruments.

🔮 What's Next

Finalization and execution of transaction documents pending and will be intimated to stock exchanges upon signing.

💡 Investor Takeaway

This financing structure may increase leverage and introduce new stakeholder dependencies for the subsidiary.

Anupam Rasayan India approved execution of security documents for Mates Visa Consultancy's up to INR 300 crore private placement of senior secured redeemable non-convertible debentures, including a first-ranking pledge over Mates' equity, an unconditional corporate guarantee from the parent company, and a call option agreement with Purebliss Pharma Solutions for a potential 15% stake acquisition.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This

About Anupam Rasayan India Ltd (ANURAS)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹13,509.81 CrP/E: 60.0ROE: 5.3%ROCE: 8.3%Div Yield: 0.13%

View full ANURAS stock details →

📡 Get AI alerts when ANURAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANURAS — Free

💡 Ask AI about this filing

"How will the INR 300 crore debenture issuance affect ANURAS's leverage ratios?""What is the expected timeline for finalizing the Purebliss stake acquisition?""How does the call option with Purebliss impact ownership control of Mates Visa Consultancy?"

Ask AI Free →

📊 More ANURAS filings

🔴 Corporate Action — 28 September 2026Anupam Rasayan India announced it acquired an additional 2.12% stake in Bliss GVS Pharma through a 2...
🔴 Announcement — 28 September 2026Anupam Rasayan India announced it has completed the acquisition of Bliss GVS Pharma for ₹299 per sha...
Announcement — 28 September 2026Anupam Rasayan India Ltd announced that its trading window will close on October 1, 2026, and remain...
🟡 Board Meeting — 23 September 2026Anupam Rasayan India announced execution of key security documents related to a proposed INR 300 cro...
🔴 Corporate Action — 21 September 2026Anupam Rasayan India announced the allotment of 14,500 senior secured rated unlisted redeemable non-...

See all ANURAS filings →

🔥 Also filed on 17 September 2026

EICHERMOTEicher Motors LtdAnnouncement SGMARTSG Mart LtdAnnouncement NEOGENNeogen Chemicals LtdCorporate Action BRAHMINFRABrahmaputra Infrastructure LtdAnnouncement PVPPVP Ventures LtdCorporate Action SONACOMSSona BLW Precision Forgings LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANURAS files new disclosures

Track ANURAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.